These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
609 related articles for article (PubMed ID: 16920162)
1. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2. Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162 [TBL] [Abstract][Full Text] [Related]
2. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460 [TBL] [Abstract][Full Text] [Related]
3. Biallelic inactivation of BRCA2 in Fanconi anemia. Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746 [TBL] [Abstract][Full Text] [Related]
4. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant. Tebbs RS; Hinz JM; Yamada NA; Wilson JB; Salazar EP; Thomas CB; Jones IM; Jones NJ; Thompson LH DNA Repair (Amst); 2005 Jan; 4(1):11-22. PubMed ID: 15533833 [TBL] [Abstract][Full Text] [Related]
5. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations. Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491 [TBL] [Abstract][Full Text] [Related]
7. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Navarro S; Meza NW; Quintana-Bustamante O; Casado JA; Jacome A; McAllister K; Puerto S; Surrallés J; Segovia JC; Bueren JA Mol Ther; 2006 Oct; 14(4):525-35. PubMed ID: 16859999 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819 [TBL] [Abstract][Full Text] [Related]
10. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment. Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660 [TBL] [Abstract][Full Text] [Related]
12. A new complementation group of mitomycin C-hypersensitive Chinese hamster cell mutants that closely resembles the phenotype of fanconi anemia cells. Telleman P; Overkamp WJ; van Wessel N; Studzian K; Wetselaar L; Natarajan AT; Zdzienicka MZ Cancer Res; 1995 Aug; 55(15):3412-6. PubMed ID: 7614481 [TBL] [Abstract][Full Text] [Related]
13. [Complex role of the FA proteins in providing genome stability]. Kluzek K; Zdzienicka MZ Postepy Biochem; 2005; 51(4):387-94. PubMed ID: 16676573 [TBL] [Abstract][Full Text] [Related]
14. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732 [TBL] [Abstract][Full Text] [Related]
15. Changes in protein expression due to deleterious mutations in the FA/BRCA pathway. Salles D; Cabral RE; Pizzatti L; Bisch PM; Paixão JC; de Almeida CE; Seuánez HN; Cabral-Neto JB Biochem Biophys Res Commun; 2007 Dec; 364(4):755-60. PubMed ID: 17977515 [TBL] [Abstract][Full Text] [Related]
16. Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M. Bakker ST; van de Vrugt HJ; Rooimans MA; Oostra AB; Steltenpool J; Delzenne-Goette E; van der Wal A; van der Valk M; Joenje H; te Riele H; de Winter JP Hum Mol Genet; 2009 Sep; 18(18):3484-95. PubMed ID: 19561169 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Fanconi anemia fibroblasts in terms of clonogenic survival and DNA damage assessed by the Comet assay. Djuzenova CS; Flentje M Med Sci Monit; 2002 Oct; 8(10):BR421-30. PubMed ID: 12388916 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N; Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169 [TBL] [Abstract][Full Text] [Related]
19. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Ridet A; Guillouf C; Duchaud E; Cundari E; Fiore M; Moustacchi E; Rosselli F Cancer Res; 1997 May; 57(9):1722-30. PubMed ID: 9135015 [TBL] [Abstract][Full Text] [Related]
20. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2. Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]